In light of these data and the health implications of decreased fat-free mass, we recommend careful consideration before implementing SGLT2 inhibition as an adjunct to dietary counselling for weight loss in sedentary adults with obesity. Here, SLC5A2 is linked to obesity due to melanocortin 4 receptor deficiency.